Table 1.
Physical and fitness parameters of the studied population during the different days of RIF
| Parameters | Pre-experimental trial (7 days before RIF) | During the month of RIF |
Postexperimental trial (15 days after RIF) | ||||
|---|---|---|---|---|---|---|---|
| First experimental trial (1st day) | Second experimental trial (8th day) | Third experimental trial (16th day) | Fourth experimental trial (22nd day) | Fifth experimental trial (30th day) | |||
| Body mass (kg) | |||||||
| CG | 55.80±7.23 | 55.93±7.54 | 56.30±7.36 | 56.45±7.37 | 56.75±8.09 | 56.94±7.87 | 56.37±7.82 |
| EG | 56.43±9.25 | 56.35±9.56 | 56.34±9.83 | 56.12±9.70 | 55.69±9.96 | 55.20±9.94 | 56.19±9.51 |
| WC (cm) | |||||||
| CG | 31.78±2.56 | 32±2.55 | 31.96±2.22 | 32.03±2.01 | 31.79±2.33 | 32.18±2.07 | 31.91±2.20 |
| EG | 31.57±2.90 | 31.48±3.15 | 31.56±2.63 | 31.59±2.46 | 31.32±2.65 | 31.16±2.66 | 31.14±3.01 |
| HC (cm) | |||||||
| CG | 34.73±2.36 | 34.54±1.89 | 34.35±1.93 | 34.59±1.96 | 34.47±1.91 | 34.68±1.77 | 34.05±2.06 |
| EG | 34.61±2.34 | 34.33±2.39 | 34.55±2.12 | 34.61±2.07 | 34.56±1.98 | 34.45±2.30 | 34.12±2.61 |
| W-H ratio | |||||||
| CG | 0.92±0.05 | 0.93±0.05 | 0.93±0.05 | 0.92±0.03 | 0.92±0.04 | 0.93±0.04 | 0.94±0.03 |
| EG | 0.91±0.07 | 0.92±0.06 | 0.91±0.06 | 0.91±0.06 | 0.90±0.06 | 0.90±0.07 | 0.91±0.05 |
| VJT (inch) | |||||||
| CG | 14.45±2.53 | 14.81±2.63 | 14.76±2.54 | 14.86±2.66 | 14.91±2.57 | 14.79±2.61 | 14.50±2.39 |
| EG | 14.22±3.22 | 14.13±2.80 | 13.81±3.53 | 14.35±3.33 | 14.59±3.46 | 14.05±3.10 | 14.62±3.10 |
| Agility (seconds) | |||||||
| CG | 11.64±0.95 | 11.65±1.01 | 11.74±1.04 | 11.64±0.87 | 11.87±0.91 | 11.72±0.96 | 11.72±1.21 |
| EG | 11.57±1.18 | 11.66±1.05 | 11.91±1.00# | 12.04±0.81#* | 12.36±0.75#* | 12.66±0.70*** | 11.71±1.08# |
| Flexibility (inch) | |||||||
| CG | 4.00±1.23 | 4.02±1.38 | 4.17±1.32 | 4.23±1.48 | 4.28±1.45 | 4.33±1.49 | 4.09±1.47 |
| EG | 4.30±1.82 | 4.42±2.04 | 5.26±2.53#* | 4.96±2.33 | 4.86±2.31 | 5.43±2.27#* | 4.49±1.80 |
| VO2max (mL/kg/min) | |||||||
| CG | 43.73±5.13 | 43.99±4.68 | 44.96±4.84 | 44.07±4.43 | 43.77±4.91 | 44.25±3.94 | 44.05±4.91 |
| EG | 44.02±5.24 | 41.19±6.06#* | 39.23±4.41*** | 36.34±4.47#*** | 34.80±3.86#*** | 34.15±4.66#*** | 43.57±5.02 |
| HIE (seconds) | |||||||
| CG | 7.94±0.83 | 7.89±0.87 | 8.16±0.78 | 7.90±0.84 | 7.89±0.85 | 8.21±0.92 | 7.94±0.90 |
| EG | 7.67±1.95 | 7.25±1.65#** | 7.69±1.45 | 7.85±1.51 | 8.45±1.43#* | 8.68±1.42* | 7.76±1.92# |
Values are mean±SD.
One-way repeated measure ANOVA shows significant difference at the level of p<0.05 (#p<0.05).
Results of t test *p<0.05, **p<0.01, ***p<0.001 (when compared between the control and experimental groups on a specific visit).
ANOVA, analysis of variance; CG, control group (n=40); EG, experimental group (n=37); HIE, high-intensity efforts; HC, hip circumference; RIF, Ramadam intermittent fasting; VJT, vertical jump score; VO2max, maximum oxygen uptake; WC, waist circumference; W-H ratio, waist to hip ratio.